Skip Nav

Colon Cancer Research Paper


❶Studies are being done to see if using targeted therapy along with chemotherapy in earlier-stage cancers can help reduce the risk of recurrence. Researchers are studying several vaccines to try to treat colorectal cancer or keep it from coming back after treatment.

Early detection

Clinical Colorectal Cancer
Reducing colorectal cancer risk

Username Password I forgot my password Register new account. Track Your Paper Check submitted paper Due to migration of article submission systems, please check the status of your submitted manuscript in the relevant system below: Username Password I forgot my password. Track accepted paper Once production of your article has started, you can track the status of your article via Track Your Accepted Article.

Order Journal Personal subscription Institutional subscription. CiteScore values are based on citation counts in a given year e. More about CiteScore Impact Factor: Your Research Data Share your research data Visualize your data. Publishing your article with us has many benefits, such as having access to a personal dashboard: This free service is available to anyone who has published and whose publication is in Scopus. Update on Hereditary Colorectal Cancer: View All Most Downloaded Articles.

Colon Cancer Human Physiology Colon cancer is considered as a pathophsiology disease. Cancer itself is an danger word to be heard by anyone and with colon attached to cancer, it could not sound any good. Any cancer is named according to the kind of organ tissue from which it develops million people, world wide, get different type of cancer every year. Colon cancer also known as colorectal cancer, is formed in the lining of the large intestine and rectum. Colon plays an great rule in our digestive system.

The colon is known to be responsible for absorbing water from what we eat, and in addition, for collecting food waste until we are able to digest it from the body. In orders to treat a such an disease, one must learn the unique experience with symptom, diagnosis, different stages of colon cancer and the right treatment for an different stages that colon cancer is occurring. How one can define an such a disease as colon cancer?

Nearly every disease has symptoms, and some symptoms may occur until the last stages of the disease. Symptoms of colon cancer include rectal bleeding, dark stools called melena, bowel movements, gas pains, back pain, and discharge from the rectum, As the tumor in the colon grows, it block which leads to later infections or bleeding in the abdominal cavity.

As the tumor spreads, it can causes other types of problems, such as liver pains, loss of appetite, or other cancer of the organs. The diagnosed of colon cancer can be in many different ways. Two studies examined the impact of more frequent follow-up testing for cancer recurrence in colorectal cancer survivors.

Learn whether the studies showed that frequent testing improved survival. Learn what happened when people waiting for routine checkups used an app that allowed them to order their own screening test. People with FAP, an inherited condition that greatly increases their risk of gastrointestinal cancer, who took the drugs erlotinib Tarceva and sulindac Aflodac saw a substantial decrease in the number of precancerous lesions in the colon and rectum.

Fusobacterium, found in the stomach and intestines, may help fuel the growth of colorectal cancer and metastases. In a mouse model of colorectal cancer, using antibiotics to kill these bacteria slowed tumor growth. Proactive, low-tech outreach approaches can help increase the number of people who get screened for colorectal cancer with a colonoscopy or home stool test and complete the appropriate follow-up.

A shorter course of chemotherapy following surgery may be preferred to longer treatment for some patients with colon cancer, results of an international collaborative study suggest. Philip Rosenberg and William Anderson of NCI discuss a recent study on which they were coauthors that reported an increase in colorectal cancer incidence among adults under age 50 in the United States.

In a study of an immune therapy for colorectal cancer that involved a single patient, researchers identified a method for targeting the cancer-causing protein produced by a mutant form of the KRAS gene. A blog post on a study showing that in patients with metastatic colorectal cancer, the location in the colon where the tumor originated appears to strongly influence how long patients live.

African Americans younger than age 50 had significantly worse 5-year survival rates at every stage of disease compared with young white and Hispanic patients, a new study shows.

In a small clinical trial of people with an inherited condition that greatly increases gastrointestinal cancer risk, a two-drug combination shrank precancerous lesions in the duodenum. A missing hormone in obese mice may help explain a longstanding association between obesity and an increased risk of colorectal cancer in humans.

The FDA has approved a single drug that combines trifluridine and tipiracil to treat patients with metastatic colorectal cancer whose disease progressed after standard treatment. In an international randomized phase III trial, the investigational drug TAS extended the lives of patients with metastatic colorectal cancer whose disease had progressed following standard therapies.

A new study suggests that dense bacterial communities called biofilms may promote the development of some colorectal cancers. New research suggests that identifying specific changes in the gut microbiome could potentially help screen patients for colorectal cancer.

Investigators who analyzed 95 human colorectal tumor samples have determined how gene alterations identified in previous analyses of the same samples are expressed at the protein level. The integration of proteomic and genomic data, or proteogenomics, provides a more comprehensive view of the biological features that drive cancer than genomic analysis alone. In a large randomized trial involving healthy men and women aged 55 to 74, sigmoidoscopy substantially reduced the incidence of and mortality from colorectal cancer.

Long-term results from the National Polyp Study confirm that removing precancerous adenomas not only reduces the risk of colorectal cancer but also reduces the number of deaths from the disease by more than half.

Main Topics

Privacy Policy

Colon Cancer Research Papers discuss how this cancer develops in the body. Cancer is the number two leading cause of death in the United States. The disease can strike almost any part of the body and is classified as an abnormal growth of cells.

Privacy FAQs

Colorectal cancer, more commonly known as colon cancer, is a common form of cancer; It is the third most common type of cancer and the second most lethal. It is fairly common due to the numerous causes and contact with foreign substances. Cancer is the condition of where cells do not cease mitosis, and continue to duplicate in tumors.5/5(1).

About Our Ads

- Colorectal cancer: Colorectal cancer, also known as bowel cancer, is found in the colon and the rectum and has become one of the most common forms of malignant cancer (Cross & Underwood, ). . Feb 21,  · Surgery that saves the anal sphincter muscle that controls the passing of stool is a rectal cancer research interest. Sometimes when colorectal cancer recurs (comes back), it spreads to the peritoneum (the thin lining of the abdominal cavity and organs inside the abdomen). These cancers are often hard to treat.

Cookie Info

This research paper will study colon cancer in detail including its signs and symptoms, causes, pathogenesis, diagnosis, prevention, management, prognosis and epidemiology. Signs and symptoms Colon cancer has varied signs and symptoms depending on its location in the large intestines, however, several signs and symptoms are common, they include. Thanks to improvements in prevention, early detection, and treatment, more than a million people in the US count themselves as survivors of colon or rectum cancer (also called colorectal cancer).